Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00732225 · ClinicalTrials.gov registry record · Phase 3
DisCoVisc Comparative Evaluation
A Phase 3 study of Cataracts, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 173
- Enrollment target
- 1
- Study location
NCT00732225: Completed Phase 3 study of Cataracts, sponsored by Alcon Research.
NCT00732225 is a Phase 3 study of Cataracts that has completed, run by Alcon Research. The registered enrollment target is 173 participants, above the 76-participant average among 8 other Cataracts trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00732225, a Phase 3 study of Cataracts, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 173 participants
- Enrollment target
- 1
- Study location
Study Summary
A comparison of the ability of DisCoVisc to that of other Opthalmic Viscosurgical Devices (OVDs) (DuoVisc®, BioVisc®, Healon5®, or Amvisc PLUS) regarding endothelial protection and anterior chamber space maintenance during non-eventful cataract surgery.
Primary Outcome
Percentage of corneal endothelial cells lost 2 months after surgery as compared to the number of corneal endothelial cells measured before the operation. Corneal Endothelial Cells are measured by counting the number of cells on an image taken by specular microscope.
Conditions Studied
Interventions
- DEVICE DisCoVisc
- DEVICE DuoVisc
- DEVICE BioVisc
- DEVICE Healon5
- DEVICE Amvisc Plus
Study Locations (1)
Texas
- Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2007-05 |
| Phase | Phase 3 |
What the finished NCT00732225 record still lists
NCT00732225 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, above the 76-participant average among 8 other Cataracts trials with a reported enrollment target (128% higher).
The record links to 1 condition, with Cataracts appearing as the primary indexed condition, and to 5 interventions - of which DisCoVisc is the first listed.
NCT00732225 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00732225 about?
NCT00732225 is a clinical study titled "DisCoVisc Comparative Evaluation". A comparison of the ability of DisCoVisc to that of other Opthalmic Viscosurgical Devices (OVDs) (DuoVisc®, BioVisc®, Healon5®, or Amvisc PLUS) regarding endothelial protection and anterior chamber space maintenance during non-eventful cataract surgery.
What is the current status of trial NCT00732225?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 173 participants. The study started on 2007-05.
What conditions does trial NCT00732225 study?
This clinical trial studies the following conditions: Cataracts.
What interventions are being tested in trial NCT00732225?
The interventions under investigation include: DisCoVisc (DEVICE), DuoVisc (DEVICE), BioVisc (DEVICE), Healon5 (DEVICE), Amvisc Plus (DEVICE).
Who is sponsoring clinical trial NCT00732225?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00732225 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataracts
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00732225's enrollment target sits among peer trials
173 1st of 8 higher than 8 of 8 other Cataracts trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataracts trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy
COMPLETED · NA
-
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
COMPLETED · Phase 4
-
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
COMPLETED · Phase 4
-
Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery
COMPLETED · Phase 4
-
Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification
COMPLETED · Phase 4
-
A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia